Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

11.18
Delayed Data
As of Jul 22
 -0.04 / -0.36%
Today’s Change
6.17
Today|||52-Week Range
20.03
-9.77%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close11.22
Today’s open11.30
Day’s range11.00 - 11.30
Volume81,897
Average volume (3 months)109,710
Market cap$329.0M
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-17.91%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.86

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.21-3.48%
AKBAAkebia Therapeutics ...+0.02+0.23%
SVASinovac Biotech Ltd+0.01+0.17%
NLNKNewLink Genetics Cor...+0.14+1.29%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.84
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs